Most recently, a role of STAT5a signaling in pre-cancerous breast lesions was also reported, where hyperprolactinemia-inducing antipsychotics were demonstrated to induce activation of STAT5a and suppress apoptosis [22]. The gene discussed is STAT5A; the disease is hyperprolactinemia.